Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 300

1.

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.

Ballenger JC, Burrows GD, DuPont RL Jr, Lesser IM, Noyes R Jr, Pecknold JC, Rifkin A, Swinson RP.

Arch Gen Psychiatry. 1988 May;45(5):413-22.

PMID:
3282478
[PubMed - indexed for MEDLINE]
2.

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.

Pecknold JC, Swinson RP, Kuch K, Lewis CP.

Arch Gen Psychiatry. 1988 May;45(5):429-36.

PMID:
3282479
[PubMed - indexed for MEDLINE]
3.

Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.

Tesar GE, Rosenbaum JF, Pollack MH, Herman JB, Sachs GS, Mahoney EM, Cohen LS, McNamara M, Goldstein S.

J Clin Psychiatry. 1987 Oct;48 Suppl:16-21.

PMID:
3312179
[PubMed - indexed for MEDLINE]
4.

Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.

Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.

J Clin Psychopharmacol. 1990 Apr;10(2):112-8.

PMID:
2187912
[PubMed - indexed for MEDLINE]
5.

Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.

Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R Jr, DuPont RL Jr.

Arch Gen Psychiatry. 1988 May;45(5):437-43.

PMID:
3282480
[PubMed - indexed for MEDLINE]
6.

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.

Noyes R Jr, DuPont RL Jr, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD.

Arch Gen Psychiatry. 1988 May;45(5):423-8.

PMID:
3358644
[PubMed - indexed for MEDLINE]
7.

Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.

Schweizer E, Patterson W, Rickels K, Rosenthal M.

Am J Psychiatry. 1993 Aug;150(8):1210-5.

PMID:
8328566
[PubMed - indexed for MEDLINE]
8.

Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.

Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR.

J Clin Psychiatry. 1986 Dec;47(12):580-6.

PMID:
3536889
[PubMed - indexed for MEDLINE]
9.

Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.

Tesar GE, Rosenbaum JF, Pollack MH, Otto MW, Sachs GS, Herman JB, Cohen LS, Spier SA.

J Clin Psychiatry. 1991 Feb;52(2):69-76.

PMID:
1993639
[PubMed - indexed for MEDLINE]
10.

Placebo response in panic disorder.

Coryell W, Noyes R.

Am J Psychiatry. 1988 Sep;145(9):1138-40.

PMID:
3046384
[PubMed - indexed for MEDLINE]
11.

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.

Schweizer E, Rickels K, Weiss S, Zavodnick S.

Arch Gen Psychiatry. 1993 Jan;50(1):51-60.

PMID:
8422222
[PubMed - indexed for MEDLINE]
12.

Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.

Munjack DJ, Crocker B, Cabe D, Brown R, Usigli R, Zulueta A, McManus M, McDowell D, Palmer R, Leonard M.

J Clin Psychopharmacol. 1989 Feb;9(1):22-7.

PMID:
2651490
[PubMed - indexed for MEDLINE]
13.

The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.

Marks IM, De Albuquerque A, Cottraux J, Gentil V, Greist J, Hand I, Liberman RL, Relvas JS, Tobeña A, Tyrer P, et al.

Arch Gen Psychiatry. 1989 Jul;46(7):668-72. No abstract available.

PMID:
2660772
[PubMed - indexed for MEDLINE]
14.

A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.

Lydiard RB, Ballenger JC, Rickels K.

J Clin Psychiatry. 1997;58 Suppl 11:11-8.

PMID:
9363043
[PubMed - indexed for MEDLINE]
15.

Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.

Dunner DL, Ishiki D, Avery DH, Wilson LG, Hyde TS.

J Clin Psychiatry. 1986 Sep;47(9):458-60.

PMID:
2875064
[PubMed - indexed for MEDLINE]
16.

Alprazolam in the treatment of panic disorders.

Liebowitz MR, Fyer AJ, Gorman JM, Campeas R, Levin A, Davies SR, Goetz D, Klein DF.

J Clin Psychopharmacol. 1986 Feb;6(1):13-20.

PMID:
2869059
[PubMed - indexed for MEDLINE]
17.

Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.

Mavissakalian MR, Perel JM.

Arch Gen Psychiatry. 1989 Feb;46(2):127-31.

PMID:
2643933
[PubMed - indexed for MEDLINE]
18.

Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.

Andersch S, Rosenberg NK, Kullingsjö H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergård M, Rasmussen S, et al.

Acta Psychiatr Scand Suppl. 1991;365:18-27.

PMID:
1862730
[PubMed - indexed for MEDLINE]
19.

Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.

Greenblatt DJ, Harmatz JS, Shader RI.

Arch Gen Psychiatry. 1993 Sep;50(9):715-22.

PMID:
8357297
[PubMed - indexed for MEDLINE]
20.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk